𝔖 Bobbio Scriptorium

✦ LIBER ✦

Pfizer-SAT2-1 - Ziprasidone: From receptor profile to patient outcomes — A review of short-term efficacy studies

✍ Scribed by F.A. Wiesel

Book ID: 119573964
Publisher: Elsevier Science
Year: 1998
Tongue: French
Weight: 137 KB
Volume: 13
Category: Article
ISSN: 0924-9338
DOI: 10.1016/s0924-9338(99)80334-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long Term Outcomes of a Phase 1/2, Multi

Long Term Outcomes of a Phase 1/2, Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of BMN 110 in Patients with Mucopolysaccharidosis IVA (Morquio A Syndrome)

✍ Christian Hendriksz; Ashok Vellodi; Simon Jones; Hiwot Takkele; S. Lee; Sarah Ch 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

DB1 EVALUATING THE COST-EFFECTIVENESS OF

DB1 EVALUATING THE COST-EFFECTIVENESS OF THERAPY CONVERSION FROM BASAL INSULIN TO BIPHASIC INSULIN ASPART 30/70 IN PATIENTS WITH TYPE 2 DIABETES IN CHINA: A MODELING STUDY OF LONG-TERM COSTS AND HEALTH OUTCOMES

✍ Chang, J; Sun, F; Li, H 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB